Zealand Pharma welcomes Jutta af Rosenborg and Jørgen Lindegaard as new board members

02-May-2011 - Denmark

Zealand Pharma announced that Jutta af Rosenborg and Jørgen Lindegaard have been elected as new members to the company’s Board of Directors at the Annual General Meeting held today. Christian Herskind Jørgensen will be leaving the Board.

At a board meeting following the Annual General Meeting, the new Board constituted itself with the re-election of Daan Ellens as Chairman and the election of Jørgen Lindegaard as Vice-Chairman.

Jørgen Lindegaard is currently a member of the board of directors of ISS Group, Trifina Holding ApS, Trifina Mellemholding ApS and Efsen Engineering A/S.  He is Chairman of the Board of Scania of Denmark A/S, AVT Business School A/S, Deducta A/S and K/S Vimmelskaftet 39-41 and Deputy Chairman of the Board of the IT University of Copenhagen. Most recently, Jørgen Lindegaard was Group CEO of the ISS Group from August 2006 to March 2010.  He also served as the CEO of SAS AB from May 2001 to May 2006 and previously served as the CEO for GN Store Nord A/S. Jørgen Lindegaard holds a Civil Engineering degree from the Technical University of Denmark.

Jutta af Rosenborg is a member of the board and Chairman of the audit committee of Auriga Industries A/S and has been a member of the board of the investment fund Carnegie WorldWide since 2006. From 2003 to 2010, Jutta af Rosenborg was CFO, Executive Vice President for Finance & IT, and member of the Board of Management of the ALK-Abelló A/S group. Jutta af Rosenborg has previously filled managerial positions at e.g. Deloitte’s auditing and consultancy department, before she was appointed Vice President Group Accounting at Chr. Hansen Holding A/S in 2000. Jutta af Rosenborg qualified as a state-authorised public accountant in 1992 and earned an MSc in Business Administration and Auditing from Copenhagen Business School in 1987. 

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances